C. Indolfi et al., 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation induced by balloon injury in vivo, J AM COL C, 36(1), 2000, pp. 288-293
Citations number
41
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES The aims of the present study were to assess 1) the effect of 8-
Cl-cAMP (cyclic-3'-5'-adenosine monophosphate) on vascular smooth muscle ce
ll (VSMC) proliferation in vitro and 2) the efficacy of systemic administra
tion of 8-Cl-cAMP on neointimal formation after balloon injury in vivo.
BACKGROUND Neointimal formation after vascular injury is responsible for re
stenosis after arterial stenting. Recently, 8-Cl-cAMP, a cAMP analogue that
induces growth arrest, has been safely administered in phase I studies in
humans.
METHODS The effect of 8-Cl-cAMP on cell proliferation was first assessed on
SMCs in vitro. To study the effects of cAMP in vivo, balloon injury was pe
rformed in 67 rats using a 2F Fogarty balloon catheter.
RESULTS The 8-Cl-cAMP markedly inhibited VSMC proliferation in vitro, reduc
ed protein kinase A (PKA) RIalpha subunit expression, and induced PKA RIIbe
ta subunit expression. In addition, 8-Cl-cAMP reduced, in a dose-dependent
manner, neointimal area and neointima/media ratio after balloon injury. The
proliferative activity, assessed by proliferating nuclear cell antigen imm
unostaining, revealed a reduction of proliferative activity of VSMCs in viv
o in the 8-Cl-cAMP group. Moreover, the systemic administration of 8-Cl-cAM
P did not affect renal function, blood pressure and heart rate.
CONCLUSIONS We conclude that 8-Cl-cAMP potently inhibits VSMC proliferation
in vitro and reduces neointima formation by balloon injury in vivo after s
ystemic administration. These data may have a clinical relevance in designi
ng future strategies to prevent restenosis after arterial stenting and perh
aps after percutaneous transluminal coronary angioplasty. (C) 2000 by the A
merican College of Cardiology.